Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Purchases 11 More Illumina Genome Analyzers

NEW YORK (GenomeWeb News) – The Wellcome Trust Sanger Institute has purchased 11 more Illumina Genome Analyzers, Illumina announced today.
The San Diego-based firm said that the Sanger Institute now has 37 of its second-generation sequencing platforms.
“The Sanger Institute has an important international role in producing and analyzing genomic data,” Julian Parkhill, director of sequencing at the institute, said in a statement. “That role is founded in DNA sequencing and we will meet new challenges by investing in appropriate new technologies.”
Terms of the purchase were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.